Gencurix, Inc.
KOSDAQTotal Valuation
Gencurix, Inc. carries a market capitalization of 26.37B, placing it among publicly traded companies globally. Its enterprise value stands at 51.20B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 26.37B |
| Enterprise Value | 51.20B |
Valuation Ratios
The price-to-sales ratio is 5.12, and the price-to-book ratio stands at -0.47.
| PE Ratio | N/A |
| PS Ratio | 5.12 |
| PB Ratio | -0.47 |
| P/TBV Ratio | 3.17 |
| P/FCF Ratio | -7.11 |
| P/OCF Ratio | -6.49 |
Enterprise Valuation
| EV / Sales | 6.45 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Gencurix, Inc. maintains a current ratio of 0.56, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 76.48, indicating elevated leverage, while an interest coverage ratio of -6.37 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.56 |
| Quick Ratio | 0.01 |
| Debt / Equity | 76.48 |
| Debt / EBITDA | -1.99 |
| Interest Coverage | -6.37 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -24.17 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.53 |
Taxes
| Income Tax | 233.72M |
| Effective Tax Rate | N/A |
Stock Price Statistics
Gencurix, Inc.'s stock has declined approximately -9.42408% over the past 52 weeks. The 50-day moving average sits at 2,493.36, while the 200-day moving average is 2,164.75.
| Beta (5Y) | N/A |
| 52-Week Price Change | -9.42408% |
| 50-Day Moving Average | 2,493.36 |
| 200-Day Moving Average | 2,164.75 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Gencurix, Inc. generated 7.94B in revenue and converted that into -7.76B in net income, yielding earnings per share of -485.56. EBITDA reached -5.39B, while operating income came in at -5.39B.
| Revenue | 7.94B |
| Gross Profit | 6.36B |
| Operating Income | -5.39B |
| Pretax Income | -7.52B |
| Net Income | -7.76B |
| EBITDA | -5.39B |
| EBIT | -5.39B |
| Earnings Per Share (EPS) | -485.56 |
Balance Sheet
Gencurix, Inc. holds 169.89M in cash and equivalents against 10.70B in total debt, resulting in a net debt position of 10.32B. Total book value stands at -86.77B, with working capital of -7.43B providing operational flexibility.
| Cash & Cash Equivalents | 169.89M |
| Total Debt | 10.70B |
| Net Debt | 10.32B |
| Equity (Book Value) | -86.77B |
| Book Value Per Share | -5,430.44 |
| Working Capital | -7.43B |
Cash Flow
Gencurix, Inc. produced -6.27B in operating cash flow over the past twelve months. After subtracting -546.59M in capital expenditures, free cash flow totaled -6.81B - equivalent to -426.29 per share.
| Operating Cash Flow | -6.27B |
| Capital Expenditures | -546.59M |
| Free Cash Flow | -6.81B |
| FCF Per Share | -426.29 |
Margins
Gencurix, Inc. operates with a gross margin of 80.10, reflecting its pricing power and cost economics. The operating margin of -67.84 and net profit margin of -97.68 provide insight into operational efficiency.
| Gross Margin | 80.10 |
| Operating Margin | -67.84 |
| Pretax Margin | -94.74 |
| Profit Margin | -97.68 |
| EBITDA Margin | -67.84 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -26.98 |
| FCF Yield | -14.06 |
Stock Splits
Gencurix, Inc.'s most recent stock split took place on March 7, 2023 with a 1000:1123 split ratio.
| Last Split Date | 3/7/2023 |
| Split Ratio | 1000:1123 |
Scores
Gencurix, Inc. posts an Altman Z-Score of -3.81, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -3.81 |